Aspen Pharmacare Hldgs (APNHF) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you, Andani. So I'm Roy Campbell. I have just recently joined Aspen Pharmacare and Investor Relations. I'm working very closely with Suneli Siwe and the management team. It's been an exciting journey so far and I do look forward into the future and looking forward to interacting with many of you as I have done over the years. Firstly to Rendani, thank you for hosting us today at your healthcare conference and we at Aspen wish you all the best over the next couple of days. So today we are presenting first half 2026 results. Mr. Steven Saad will take us through the period under review. Sean Capisario will take us through the financial highlights. And Steven then will go over the group strategy and the outlook. We will be taking questions from both the floor and over the webcast. So please submit them if you want and please just introduce yourself as you do. And I know that we'll be seeing a number of you over the next couple of days, but please feel free to get in touch if there's anything that you want to discuss. So with that, I'm going to welcome Mr. Stephen Sider. Good morning, Stephen. Thank you, Roy. Morning, everyone. Good to be here. Thank you. It's amazing what can change in less than a year. Sometimes you need the darkest moments to give us some proper introspection and to shape and reset where you are and where you're going to. Just to remind you in terms of our reset, there were really three areas that we looked at. The first was And the hardest thing about introspection is being honest. It's the biggest, but it doesn't work unless you're incredibly honest with yourselves. And so when we looked at our business and where we were, there were really, I think, three things that we could see here. Firstly, we have a commercial pharmaceutical business that ...